- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Aquestive Therapeutics (NASDAQ:AQST), Quotes and News Summary
Aquestive Therapeutics (NASDAQ: AQST)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-01 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.360 | -0.360 | 0.0000 | ||||
| REV | 10.570M | 13.265M | 2.695M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Aquestive Therapeutics Questions & Answers
You can purchase shares of Aquestive Therapeutics (NASDAQ: AQST) through any online brokerage.
Other companies in Aquestive Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by HC Wainwright & Co. on Tuesday, June 21, 2022. The analyst firm set a price target for 5.00 expecting AQST to rise to within 12 months (a possible 468.18% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $0.88 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.